Health and Medicine

September 7, 2012

Parkinson’s therapy may impact language

Deep brain stimulation used to treat Parkinson’s disease may impair some aspects of language processing, a recent study suggests.

By VUMC News and Communications
September 6, 2012

Study tracks hormone’s role in reducing preterm birth risk

Pregnant women who have had prior preterm births may avoid a subsequent early birth if given progestogens, which are natural or synthetic forms of progesterone, a female hormone that naturally increases during pregnancy, a Vanderbilt analysis shows.

By Nancy Humphrey
September 6, 2012

BioVU reaches new benchmark in DNA samples

This month BioVU logged in its 150,000th unique genetic sample. It is now the world’s largest collection of human DNA linked to searchable, electronic health information.

By Bill Snyder
September 6, 2012

Neuronal subtypes in genetic disorder

Inhibitory neurons that connect and regulate signaling in the brain (interneurons) may contribute to epilepsy and autism in patients with tuberous sclerosis complex.

By Leigh MacMillan
August 30, 2012

Conte Center receives grant to study serotonin

The Silvio O. Conte Center for Neuroscience Research at Vanderbilt has received a $10.5 million federal grant to continue its groundbreaking research on serotonin signaling in the brain for another five years.

By Bill Snyder
August 30, 2012

Vanderbilt-led study reveals racial disparities in prostate cancer care

Racial differences exist in quality surgical care, new research from VICC finds.

By VUMC News and Communications
August 30, 2012

Targeting new pathways to ease pain

The spinal cord’s neuropeptide Y signaling pathway may be a good target for new pain therapeutics.
By Leigh MacMillan
August 28, 2012

Clues to retinal cell degeneration

A reversible chemical modification of rhodopsin, a receptor for light, plays a role in the degeneration of retinal cells.
By Leigh MacMillan
August 27, 2012

Little evidence supports autism treatment options in adolescents

There is insufficient evidence to support findings, good or bad, for therapies currently used in adolescents and young adults with autism.
By VUMC News and Communications
August 24, 2012

Tool helps plumb electronic records

A tool developed for one institution’s electronic health records can work at other institutions, potentially facilitating the use of these records in research studies.
By VUMC News and Communications
August 23, 2012

VU, Lipscomb partner on dual degree program

A new cooperative program between Vanderbilt University and Lipscomb University’s College of Pharmacy is focusing on the next generation of pharmaceutical researchers. By offering a pathway for students to earn both Pharm.D. and Ph.D. degrees, the program aims to boost the number of pharmacy-trained research scientists.
By Leigh MacMillan
August 23, 2012

Gene linked to familial prostate cancer

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.
By VUMC News and Communications
August 16, 2012

Method may refine personalized trials for cancer therapy

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.
By VUMC News and Communications
1 … 166 167 168 169 170 … 197